The effects of melatonin, amlodipine, diltiazem (L-type Ca 2+ channel blockers) and v-conotoxin (N-type Ca 2+ channel blocker) on the glutamate-dependent excitatory response of striatal neurones to sensory-motor cortex stimulation was studied in a total of 111 neurones. Iontophoresis of melatonin produced a signi®cant attenuation of the excitatory response in 85.2% of the neurones with a latency period of 2 min. Iontophoresis of either L-or N-type Ca 2+ channel blocker also produced a signi®cant attenuation of the excitatory response in more than 50% of the recorded neurones without signi®cant latency. The simultaneous iontophoresis of melatonin+amlodipine or melatonin+diltiazem did not increase the attenuation produced by melatonin alone. However, the attenuation of the excitatory response was signi®cantly higher after ejecting melatonin+v-conotoxin than after ejecting melatonin alone. The melatonin±Ca 2+ relationship was further supported by iontophoresis of the Ca 2+ ionophore A-23187, which suppressed the inhibitory effect of either melatonin or Ca 2+ antagonists. In addition, in synaptosomes prepared from rat striatum, melatonin produced a decrease in the Ca 2+ in¯ux measured by Fura-2AM¯uorescence. Binding experiments with [
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Melatonin has been suggested to be a neuroprotective molecule due to its antioxidant (1, 2) and inhibitory effects on the central nervous system (3) . The inhibitory effects of melatonin may involve modulation of brain GABA and benzodiazepine receptors (4, 5) , possibly explaining the anticonvulsant, anxiolytic and hypnotic properties of melatonin that have been reported elsewhere (6) .
Clinical use of melatonin is bene®cial in several human diseases, such as Parkinson's disease (7) and epileptic seizures (8) . Whereas Parkinson's disease is due to the neurodegeneration of nigroestriatal pathway leading to alterations in dopamine/glutamate equilibrium and central motor alteration (9) , epileptic seizures frequently involve glutamate receptor activation and excitotoxicity (10) . In several experimental models of neurodegeneration, including ageing, MPTPinduced Parkinson's disease, glutamate-or b-amiloid-induced excitotoxicity and drug-induced epilepsy, melatonin has been reported to be antiexcitotoxic (11±16). To assess the relationship between melatonin and excitotoxicity, the interaction of the indoleamine with glutamatergic striatal activity in rats was studied. Iontophoresis of melatonin inhibits both spontaneous striatal activity (17, 18) , and activity evoked by sensory-motor cortex stimulation (SMCx) (19) . Since the receptors activated in this cortico-striatal circuit are glutamatergic (20) , an interaction between melatonin and glutamate was suggested.
The mechanisms by which melatonin inhibits the glutamate-mediated response are not clear. Glutamate-induced excitotoxicity is mediated, at least partially, by an increase in intracellular Ca 2+ (21) . An excessive intracellular Ca 2+ concentration contributes to a variety of neurodegenerative processes including ageing, chronic epilepsy and brain damage associated to cerebral ischaemia and trauma (10) . Melatonin could act primarily to inhibit Ca 2+ in¯ux (22, 23 ) through modulation of voltage-dependent Ca 2+ conductances (24) .
The present study addressed the question of whether melatonin inhibition of glutamatergic responses in the central nervous system is mediated by a reduction in Ca 2+ in¯ux. 
Materials and methods

Animals and drugs
Adult male Wistar rats weighing 250±325 g were obtained from the Granada University facility. The rats were fed ad libitum and maintained in clear plastic cages under controlled lighting conditions (12 : 12 h light : dark cycle; lights on at 07.00 h) at a temperature of 22±24uC for at least 7 days before experiments. Experiments were carried out according to the European Union guidelines.
All reagents were of analytical grade and obtained from commercial sources. Melatonin, v-conotoxin GVIA, A-23187, L-glutamate and L-glycine were obtained from Sigma-Aldrich (Madrid, Spain). Amlodipine and diltiazem were kindly supplied by P®zer Laboratories (Spain) and Dr Esteve Laboratories (Barcelona, Spain), respectively. MK-801 was obtained from Research Biochemicals International (Nantick, MA, USA). [ 3 H]MK-801 was obtained from New England Nuclear-Dupont (Itisa, Spain; speci®c activity 20.3 Ci/mmol).
Electrophysiological experiments
Rats were anaesthetized with urethane (1.2 g/kg, i.p.) and mounted in a stereotaxic apparatus, with the incisor bar 4 mm below the ear bars. Body temperature was maintained at 36.5±37.5uC with a rectal probe and an electrically regulated heating pad. Recording electrodes were lowered through burr holes in the skull to the striatum, using the coordinates + 1.3 to x0.7 mm to the Bregma, 1±2.5 mm lateral to the sagittal sinus, and 3±7 mm below the dura. Stimulating electrodes were placed in the SMCx at the coordinates 1.5 mm anterior to the Bregma; 1.5 mm lateral to the sagittal sinus and 1.5 mm below the dura. Glass microelectrodes ®lled with 0.5 M sodium acetate and 2% pontamine sky blue dye, with a tip of 1 mm diameter and an impedance of 6±9 MVu at 1 kHz, were used to record extracellularly from single units in the striatum. Electrical stimulation was applied to the SMCx, using two monopolar stainless steel electrodes (Rhodes Medical NE-200X, CA, USA, 1 mm separation). Single monophasic square wave pulses (0.2 ms duration, 100±200 nA intensity, and 0.5 Hz frequency) were generated by a digital stimulator coupled with a stimulus isolation unit. Signals recorded from the microelectrode were digitized and sampled by a computer that recorded spike frequencies and interspike intervals with a resolution of 1 ms. In microiontophoresis experiments, 5-barrel glass micropipettes assembled to the recording micropipette were used. Retention current was + 3 nA. The procedure has been previously published (19, 25) . Striatal neurones with excitatory response to sensory-motor cortex stimulation were selected to study the effects of melatonin and/or Ca 2+ channel blockers by microiontophoresis. In the ®rst group, melatonin iontophoresis was performed and the time-course of the response was studied. Melatonin was iontophoretized for 2 min (1 mM, 3% ethanol, pH 5.6, x100 nA) and the response was recorded. Following this period of ejection, and without melatonin iontophoresis, the excitatory response was recorded in 2-min intervals.
After melatonin iontophoresis, and once the recorded striatal neurone recovered basal level of excitation (normally after 6±8 min), amlodipine (0.1 mM, pH 6.5, + 100 nA), diltiazem (1 mM, pH 5.5, + 100 nA), v-conotoxin (0.1 mM, pH 6.5, x100 nA) or A-23187 (0.01 mM, pH 6.5, x100 nA) dissolved in bidistilled water were iontophoretized alone or in combination with melatonin, always through a different micropipette. In some rats, the drugs were ejected by pressure (Picospritzer II, General Valve Co. Fair®eld, NJ, USA, 30 psi during 2 min).
Controls were made regularly, passing current of the same intensity and polarity through the solvent. The excitatory response did not change in any case. Only those neurones that at the end of the experiment recovered basal levels of excitation, were used in this study. At the end of each track, recording sites were marked by passing a negative current of 10 mA for 10 min to eject pontamine sky blue dye into the brain. Electrical stimulation sites were marked by passing an anodal current of 10 mA for 1 min to leave an iron deposit. Rats were perfused through the heart with saline and buffered formaline containing 3% of potassium ferricyanide. The brain was then removed and ®xed with a solution of 10% of paraformaldehyde for 24 h and sectioned on a freezing microtome at 70 mm, and the recording sites were determined histologically.
Fura-2AM experiments
[Ca
2+
] i was measured in synaptosomes prepared from the rat striata as elsewhere described (26) . All the procedures were carried out at 0±4uC. Brie¯y, the striata were chopped and homogenized in 0.32 M sucrose, 5 mM HEPESNa + pH 7.4 with a Stuart Scienti®c SS-2 homogenizer at 600 r.p.m. The homogenate was centrifuged at 1000 g for 10 min. The pellet was resuspended in a sucrose buffer and centrifuged again. Both supernatants were combined and centrifuged at 12 000 g for 20 min. The resultant pellet was resuspended in a sucrose buffer. A two layer sucrose buffer gradient was prepared by layering 3 ml of the membrane preparations on top of 6 ml 0.8 M sucrose buffer. The gradient was centrifuged at 9000 g for 30 min. The 0.8 M layer was collected and diluted with 2.5 volumes of Ca 2+ -free buffer (10 mM HEPES-Na + , pH 7.4, 145 mM choline chloride, 5 mM KCl, 1.2 mM MgCl 2 , 5.5 mM glucose). The synaptosomes were collected after centrifugation for 6 min at 20 000 g and resuspended in Ca
-free buffer to give a concentration of 2±3 mg protein/ml as measured by the BioRad assay (Biorad Laboratories, Richmond, CA, USA). Aliquots of 500 ml were frozen on dry ice and stored at x80uC until used. Such freezing does not affect the results of Fura-2AM measurements. 
H]MK-801 binding
Rats were killed by neck dislocation and well-washed striatal membranes were prepared following a method described elsewhere (27) . The brains were removed and the striata were dissected and quickly frozen at x80uC for 24±48 h. After thawing, the tissue was homogenized in 10 vol of ice-cold 0.32 M sucrose using a Polytron (Brinkmann Instruments, Westburg, NY, USA) in position 6 for 30 s. All further procedures were carried out at 4uC. Homogenates were centrifuged at 1000 g for 10 min and the supernatant was centrifuged at 10 000 g for 20 min. The upper buffy coat layer of the pellet was suspended in 20 vol of ice-cold water and centrifuged at 50 000 g for 20 min. The water washing step was repeated three times and the resultant pellet stored at x80uC for at least 18 h. On the day of the binding assay, membrane pellets were thawed at room temperature for 30 min, suspended in 20 vol 5 mM TrisHCl buffer pH 7.4, centrifuged at 50 000 g for 20 min and given a further four cycles of washing. In each cycle, the membranes were resuspended in 5 mM Tris-HCl buffer pH 7.4, incubated at room temperature for 20 min, and centrifuged at 50 000 g for 20 min. After the ®nal centrifugation, the pellets were resuspended in 5 mM Tris-HCl pH 7.4 at 23uC, to a ®nal concentration of 0.3±0.5 mg protein/ml. Protein content was determined by the method of Lowry et al. (28) . This well-washed membrane preparation eliminates endogenous glutamate (27) . In addition, this membrane preparation permits to investigate the modulatory action of exogenous divalent cations under a condition where the chronic in¯uence of endogenous L-glutamate, L-aspartate and L-glycine on [ ]MK-801 and test substances in triplicate. Nonspeci®c binding was determined by the addition of 100 mM unlabeled MK-801. The mixture was incubated for 60 min at 23uC and incubation was stopped by rapid ®ltration through Whatman GF/B ®lters in a LKB-Wallac 1295±001 Cell Harvester (Perkin Elmer Life Sciences, Boston, MA, USA), followed by two 4-ml washes with ice-cold assay buffer (within 10 s). Radioactivity on the ®lters was determined by liquid scintillation counting in plastic vials with 10 ml of Ecoscint H (National Diagnostics, Atlanta, GA, USA) at 45% ef®cience in a Beckman LS-6000 system (Beckman Coulter Inc., Fullerton, CA, USA). The nonspeci®c binding was 10±15% of total binding. Kinetic parameters (K D and B max ) and IC 50 values were measured from the displacement curves, obtained using at least ®ve concentrations of each displacer (in triplicate), by means of the Ligand-PC program (KELL software, Biosoft, Cambridge, UK).
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Statistical analysis
One-and two-way analysis of variance (ANOVA I and II) followed by the Dunnett's test were used to decide the existence of signi®cant differences in the total responsiveness, the direction (>25% increase or decrease was considered signi®cant) and the latency of the responses among neurones treated with different drugs. P<0.05 was considered statistically signi®cant. This statistical analysis was also applied to the binding data.
Results
Electrophysiological experiments
During the experiments, electrical stimulation was applied continuously to the deep layers of SMCx. Recordings were made from a total of 111 neurones in the dorsal portion of the striatum. Most of the neurones in this region were quiescent unless excited by cortical stimulation. The latency of the excitatory response was relatively short (range 5±8 ms). The response consisted of one or two action potentials, without bursting (19, 25) . The latency of activation of a given neurone showed little¯uctuation and usually appeared in the poststimulus time histogram as a narrow peak (Fig. 1 ). Iontophoretic application of melatonin attenuated the excitatory response of striatal neurones to cortical stimulation in 40 (85.2%) of 47 recorded neurones, whereas seven (14.8%) of them showed no effect, or responded with an increase in the excitatory response after melatonin ejection. The excitatory response of neurones was analysed in periods of 2 min with a resolution of 1 ms (Fig. 2) . After the ®rst interval (basal period), melatonin was ejected in the period of 0±2 min, and most of the neurones did not modify the excitatory response to motor cortex stimulation. In the second (2±4 min) and third (4±6 min) intervals, 63.3% and 36.7% of the responding neurones showed a signi®cant attenuation in the excitatory response, respectively. During the following two intervals (6±10 min), 100% of the neurones recovered the preiontophoresis levels (Fig. 2) . Similar effects were obtained with pressure ejections of melatonin (21 neurones tested).
Another group of 64 neurones was used to study the effects of the Ca 2+ channel blockers alone or in combination with melatonin following the same experimental paradigm. The protocol for the ejection of amlodipine, diltiazem and v-conotoxin comprised: (i) the Ca 2+ channel blocker was applied iontophoretically for 2 min; the response always returned to control levels when the iontophoresis was stopped.
(ii) melatonin was iontophoretized for 2 min, and the latency of the maximal attenuation was noted. (iii) When the excitatory response recovered to basal levels, melatonin was iontophoretized, again for 2 min, and the Ca 2+ channel blocker was applied when the attenuation induced by melatonin was maximal, to search any melatonin-Ca 2+ antagonist interaction. This protocol was identical for each Ca 2+ antagonist tested.
To study the effect of the L-type Ca 2+ channel blocker amlodipine, 25 neurones were recorded and amlodipine was iontophoretically ejected. Thirteen of the neurones tested (52%) attenuated their excitatory response, two neurones (8%) showed enhancement of the response, and 10 (40%) did not alter the excitatory response. When amlodipine was iontophoretized with melatonin, the attenuation of the excitatory response was similar to that found after individual ejection of these compounds (Fig. 3A) .
Diltiazem, another L-type Ca 2+ channel blocker, was tested on 22 neurones. Iontophoresis of diltiazem attenuated the excitatory response of 14 of the neurones (63.6%), increased the response of two neurones (9.1%), and had no effect on the response of six neurones (27.3%). Simultaneous iontophoresis of diltiazem and melatonin did not signi®cantly modify the attenuation of the excitatory response compared with that found after individual ejection of these compounds (Fig. 3B) .
To test the N-type Ca 2+ channel blocker, 17 neurones were recorded, and v-conotoxin was iontophoretically ejected. Ten of the neurones (58.8%) attenuated their excitatory response and seven (41%) did not change the response. When v-conotoxin plus melatonin were simultaneously iontophoretized, the attenuation of the excitatory response was signi®cantly greater than the response obtained with each compound individually (Fig. 3C) .
The effects of the Ca 2+ ionophore A-23187 on the excitatory response of the striatal neurones to SMCx stimulation were studied in 74 neurones. Iontophoresis of A-23187 did not change the basal excitatory response to SMCx stimulation of the striatal neurones (Fig. 3) . To assess any interaction with melatonin, we looked for neurones with attenuating response to melatonin ejection (22 neurones); when the neurone recovered basal level of response, ionophore was ejected with melatonin. The ionophore was also simultaneously ejected with amlodipine (18 neurones, Fig. 3A), diltiazem (16 neurones, Fig. 3B) or v-conotoxin (18  neurones, Fig. 3C ) alone or in combination with melatonin. In every case, iontophoresis of A-23187 counteracted the inhibitory effects of both melatonin and the Ca 2+ antagonists on the excitatory response of the striatal neurones.
Ca 2+ in¯ux in striatal synaptosomes
To further assess an effect of melatonin on Ca 2+ in¯ux into the cell, the effect of indoleamine was tested in synaptosomes incubated with Ca 2+ . After preincubation with 5 mM Fura-2AM, synaptosomes were incubated with 1 mM CaCl 2 and Ca 2+ in¯ux into the synaptosomes was induced by depolarization with 40 mM KCl. Different concentrations of melatonin (10±500 mM) or vehicle were then added to the synaptosomes and changes in Ca 2+ in¯ux were monitored. Melatonin decreased, in a dose-dependent manner, the Ca 2+ in¯ux into the synaptosomes (Fig. 4A) . The maximal reduction of intrasynaptosomal Ca 2+ (53% of basal) was reached with 25 mM melatonin (P<0.001). At a concentration of 25 mM melatonin maintained a reduced intrasynaptosomal Ca 2+ levels for at least 120 min (Fig. 4B, P<0 .001).
Binding experiments
Because the electrophysiological pattern of melatonin response was similar to that of MK-801, and the indoleamine potentiated the effect of Mg 2+ on the NMDA receptor, we investigated whether melatonin inhibits the NMDAsubtype of glutamate receptor. To test this hypothesis, a series of binding experiments were carried out. Figure 5 (A) shows a typical competition experiment with unlabelled MK-801 (1±200 nM) in the absence or presence of different doses of melatonin. Melatonin (1 mM or 100 mM) was unable to modify the displacement curve for MK-801. Melatonin alone (Fig. 5B ) did not compete with the binding site of [ 3 H]MK-801, and the presence of cold MK-801 only displaced the percentage of binding corresponding to the dose of this drug. In the presence of Mg 2+ , the competition curve for MK-801 was displaced to the left, an effect further increased by 1 mM melatonin (Fig. 5C ). As seen in Table 1 . The presence of 10 nM MK-801 or 10 nM MK-801 plus 1 mM melatonin signi®cantly (P<0.05) reduced the IC 50 for Mg 2+ to 1.2t0.2 mM and 1.3t0.4 mM, respectively. However, incubation with 1 mM alone (without MK-801) did not modify the IC 50 for Mg 2+ (3.7t0.5 mM). The effect of melatonin in modifying the af®nity of MK-801 binding site, dependent on the presence of both Mg 2+ and cold MK-801, was further analysed. In the absence of MK-801, melatonin (1±100 mM) had no effect on the displacement curve of Mg 2+ (Fig. 5E ).
Mg 2+ was unable to induce melatonin effects on [ 3 H]MK-801 binding, and different doses of the cation only displaced the percentage of binding corresponding to its dose (Fig. 5F ).
Discussion
The present results show that melatonin attenuates the excitatory response of striatal neurones to SMCx stimulation, and that this effect may be mediated by a reduction of Ca 2+ in¯ux through voltage-sensitive Ca 2+ channels. Iontophoresis of L-type Ca 2+ channel blockers (amlodipine and diltiazem) showed inhibitory effects on the striatal excitatory response that were similar to those obtained with melatonin. When both (L-type Ca 2+ channel blocker and melatonin) were ejected simultaneously, their effects were not additive. On the other hand, v-conotoxin (N-type Ca 2+ channel blocker) also attenuated the response to SMCx stimulation, and its simultaneous ejection with melatonin produced additive effects. The fact that the Ca 2+ ionophore A-23187 suppressed the inhibitory effect of melatonin and that the indoleamine decreased Ca 2+ in¯ux in striatal synaptosomes, further support the Ca 2+ -dependent inhibitory action of melatonin on striatal neurones.
L-type Ca 2+ channels are present in many cells, including postsynaptic membranes, whereas N-type Ca 2+ channels are generally restricted to neurotransmitter release sites at presynaptic level (29) . Both types of Ca 2+ channels have been described in the striatum (30), a brain area that actively uptakes melatonin after its peripheral administration (31) . Thus, v-conotoxin, acting through N-type Ca 2+ channels, decreased the neurotransmitter release and hence, the excitatory response on the postsynaptic neurone. If melatonin blocks L-type Ca 2+ channels, the simultaneous ejection of melatonin and v-conotoxin results in an additive effect on the attenuation of the excitatory response.
The results showing the similar effects of melatonin and L-type Ca 2+ channel antagonists are consistent with the interpretation that they block Ca 2+ in¯ux through the same channels. This explanation agrees with recent data (23, 24) showing similar effects of melatonin and nifedipine and the inorganic Ca 2+ channel blocker Co 2+ , whereas Bay K (which elevates Ca 2+ by preventing closure of L-type channels) and the Ca 2+ ionophore A-23187 prevented the inhibitory effects of melatonin on LH release. Thus, these data support the hypothesis that melatonin inhibits Ca 2+ in¯ux through 464 Melatonin, glutamate and Ca 2+ in rat striatum voltage-sensitive Ca 2+ channels, although an effect of melatonin on neurotransmitter release cannot be discarded. Nevertheless, the different onset latency of melatonin and of Ca 2+ antagonists suggests that the effects of melatonin are not produced by a direct action of the indoleamine on Ca 2+ channels.
Melatonin is a lipophilic molecule and data supporting the permeability of membranes to indoleamine have been reported. Recent experiments have shown that melatonin counteracts oxidative stress-induced reduction in membranē uidity (32) . Although an indirect effect on Ca 2+ mobilization through this membrane-related effect of melatonin cannot be excluded, the membrane effects of melatonin were produced at concentrations ranging from 0.1 to 1 mM whereas our results support the effects of melatonin at lower doses (it is considered that the applied iontophoretic current only releases a small amount of the ejected drug).
The long latency for melatonin response is shared by other structurally related drugs such as kynurenines. In striatal slices, depression caused by kynurenic acid began 1±2 min after the drug reached the tissue and achieved its maximal amplitude 3±5 min later (33) . Kynurenic acid is a broadband antagonist of glutamate receptors, although with preference to the NMDA receptor type. Thus, the inhibitory effect of melatonin would be due not only to the inhibition of Ca 2+ in¯ux through voltage-sensitive channels, but also through NMDA-gated Ca 2+ channels. Because the excitatory response recorded in our experiments is glutamate-mediated (20) , it seems possible that melatonin may interact with the NMDA-subtype of glutamate receptor.
To study any effect of melatonin on the NMDA-gated Ca 2+ channel, binding experiments were conducted in rat striatal membranes using (34) . Melatonin alone did not modify these kinetic parameters. However, melatonin reinforced the ability of Mg 2+ to decrease both K D and B max , re¯ecting an increase in the binding af®nity of dizocilpine to its site at the NMDA-gated Ca 2+ channel. Hill analysis showed nH values between 0.97 and 0.98, thus discarding the existence of cooperativity and/or other sideeffects of melatonin on the binding. These results agree with previous reports showing an additive effect of melatonin and Mg 2+ on the striatal excitatory response to SMCx stimulation when both compounds were simultaneously iontophoretized (35) . The ability of melatonin to reduce low-Mg 2+ epileptiform activity in human temporal slices (12) further supports that the melatonin±Mg 2+ interaction is a common ®nding that may explain, at least in part, the inhibitory role of melatonin on brain glutamatergic excitability.
The characteristic of melatonin-induced inhibition of the striatal excitatory response is the long latency of its response (2±4 min). A possible explanation comes from experiments showing that the inhibitory action of melatonin on the excitatory response here described might re¯ect a primary effect of the indoleamine, i.e. membrane hyperpolarization. Hyperpolarization reduces intracellular Ca 2+ in¯ux by closing voltage-sensitive Ca 2+ channels (24) . The mechanism through which melatonin causes hyperpolarization appears to involve Na + (36) . Either the exclusion of Na + from the culture medium or the incubation with the sodium pump inhibitor ouabain, blocks the hyperpolarizing effect of melatonin (24, 36, 37) . The presence of Ca 2+ is necessary for striatal neurones to depolarize in response to glutamate (33) . Thus, the indirect, hyperpolarizing-dependent Ca 2+ channel blocking effect of melatonin might explain, at least in part, the long latency for the inhibiting effect of melatonin on the response here studied.
Taken together, these results support the idea that decreased Ca 2+ in¯ux is involved in the inhibitory effect of melatonin on NMDA receptor activity. Activation of NMDA receptors depends on the relief of the voltage-sensitive Mg 2+ -block site inside the NMDA receptor channel pore, which in turn may affect current and Ca 2+ in¯ux through both L-type Ca 2+ channels and activated NMDA receptor channels (38) . Melatonin enhances the inhibitory effect of Mg 2+ on the NMDA receptor activity (35) , and increases the binding af®nity of MK-801 to the NMDA-gated Ca 2+ channel. Thus, as a result of melatonin ejection, the NMDA receptor channel pore remains closed, avoiding the opening of L-type Ca 2+ channels and Ca 2+ in¯ux. Following on from the relationships between melatonin and kynurenines, we recently showed that synthetic melatoninrelated kynurenines decreased brain striatal NMDA excitability in a dose-dependent manner. Some of these kynurenines showed 100 times more potency than melatonin itself in this response. The effects of these drugs, including melatonin, were linked to their inhibition of neuronal nitric oxide synthase (nNOS) activity and the decrease in nitric oxide (NO) production and were not due to their interaction with melatonin membrane receptors (39, 40, 41) . NO is a messenger of the NMDA-subtype of glutamate receptors (42) and it is produced in response to Ca 2+ in¯ux that binds to calmodulin resulting in the Ca 2+ -calmodulin-mediated NOS activation (43) .
Our results demonstrate the inhibitory role of melatonin on brain glutamate excitability through a mechanism partially involving a decrease in Ca 2+ in¯ux. The NMDA-mediated generation of NO depends on Ca 2+ in¯ux by both NMDAgated and L-type Ca 2+ channels (44) . An over¯ow of Ca 2+ leads to excessive NO production that, in turn, yields the dangerous free radical peroxynitrites. In addition, NO ef¯ux from the cell increases presynaptic glutamate release leading to more NO production. Taken together, the inhibition of Ca 2+ in¯ux described here, and the role of melatonin as a free radical scavenger reported elsewhere (1±3), support the antiexcitotoxic effects of melatonin.
